Picture loading failed. Picture loading failed.

GeneMedi's Ion Channel portfolio for drug discovery and mechanism of action (MOA) research.

GeneMedi's portfolio of Ion Channels offers an extensive range of highly selective ligands and agonists/antagonists that are perfect for target validation and drug discovery projects. Ion channels, which are integral membrane proteins that facilitate the flow of ions across the cell membrane, play a critical role in regulating various biological processes such as cell signaling, neuronal excitability, and muscle contraction. As such, they have become an important focus for drug discovery in the pharmaceutical industry. Classification based on their selectivity for particular ions and their structural properties has yielded three families of ion channels, namely voltage-gated ion channels, ligand-gated ion channels, and mechanically-gated ion channels. Each category consists of several vital proteins with unique functions and therapeutic applications. For example, sodium channels, potassium channels, and calcium channels are involved in the control of neuronal excitability and muscle contraction and belong to the voltage-gated channel category. Nicotinic acetylcholine receptors, serotonin receptors, and glutamate receptors, among others, are part of the ligand-gated ion channels family and are involved in neurotransmission, pain modulation, and memory and learning. Mechanically-gated ion channels include stretch-activated channels that regulate cell volume in response to changes in osmotic pressure. The identification and targeting of specific ion channels and their associated signaling pathways have resulted in the development of several diagnostic and therapeutic applications. These channels are implicated in diseases such as epilepsy, arrhythmias, and neuropathic pain. Consequently, they represent attractive targets for drug development. Several drugs, including calcium channel blockers, potassium channel activators, and sodium channel blockers, have targeted ion channels and been approved for the treatment of various diseases. Ion channels are also used as diagnostic markers for certain diseases, such as cystic fibrosis and long QT syndrome, with dysregulated ion channels linked to their development and progression.

Overall, ion channels offer significant potential in drug discovery and development, making them an attractive class of therapeutic targets. Their complexity in signaling pathways and functions makes them highly relevant for diagnostics and therapeutics, with their classification and identification offering an opportunity for precision medicine and personalized therapies.

At GeneMedi, we provide benchmark antibodies for various research applications involving Ion Channels, including mechanisms of action (MOA) research, ELISA, affinity binding assays, and drug discovery. Our pre-made monoclonal antibodies (mAbs), expressed using mammalian cell lines, ensure high quality and reproducibility. These mAbs serve as reference therapeutic antibodies in cell culture, assay development, animal model development, PK/PD model development (pharmacokinetics & pharmacodynamic), and MOA research for biological drug discovery.


Q1. What is GeneMedi's Ion Channel portfolio?
A1: GeneMedi's Ion Channel portfolio comprises a range of selective ligands and agonists/antagonists designed for drug discovery and target validation projects.

Q2. What are ion channels?
A2: Ion channels are integral membrane proteins responsible for regulating various biological processes, such as cell signaling, muscle contraction, and neuronal excitability.

Q3. What are the classifications of ion channels?
A3: Ion channels have three classifications based on their selectivity for particular ions and structural properties: voltage-gated, ligand-gated, and mechanically-gated ion channels.

Q4. Why are ion channels attractive targets for drug development?
A4: Ion channels play a role in the development and progression of diseases such as epilepsy, arrhythmias, and neuropathic pain, making them attractive targets for drug development.

Q5. What research applications does GeneMedi provide for Ion Channels?
A5: GeneMedi provides benchmark antibodies for research applications concerning Ion Channels like ELISA, drug discovery, MOA research, and affinity binding assays.

Email: [email protected]   [email protected]
Telephone: +86-21-50478399   Fax: 86-21-50478399
Privacy Policy